Gili Regev-Yochay

Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.

Lustig Y, Barda N, Weiss-Ottolenghi Y, Indenbaum V, Margalit I, Asraf K, Doolman R, Chalkias S, Das R, Elfatarany G, Harats D, Kreiss Y, Regev-Yochay G.

Vaccine. 2024 May 27. PMID: 38806352

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.

Lustig Y, Canetti M, Indenbaum V, Peretz Y, Weiss-Ottolenghi Y, Margalit I, Asraf K, Levin T, Zuckerman N, Tomer E, Mandelboim M, Doolman R, Barda N, Regev-Yochay G.

Emerg Infect Dis. 2024 May. 30(5):1050-1052. PMID: 38666742

Obstetric and Early Neonatal Outcomes Following Second and Third COVID-19 Vaccination in Pregnancy.

Peretz-Machluf R, Gilboa M, Bookstein-Peretz S, Segal O, Regev N, Meyer R, Regev-Yochay G, Yinon Y, Toussia-Cohen S.

Isr Med Assoc J. 2024 Jan. 26(1):12-17. PMID: 38420636

Sink-traps are a major source for carbapenemase-producing Enterobacteriaceae transmission.

Regev-Yochay G, Margalit I, Smollan G, Rapaport R, Tal I, Hanage WP, Pinas Zade N, Jaber H, Taylor BP, Che Y, Rahav G, Zimlichman E, Keller N.

Infect Control Hosp Epidemiol. 2024 Mar. 45(3):284-291. PMID: 38149351

Corrigendum to "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" [Clin Microbiol Infect] 29 (7) (2023) 918-923.

Barda N, Lustig Y, Indenbaum V, Zibly D, Joseph G, Asraf K, Weiss-Ottolenghi Y, Amit S, Kliker L, Abu-Kadar B, Ben-Ami E, Canetti M, Koren R, Katz-Likvornik S, Halpern O, Mendelson E, Doolman R, Harats D, Kreiss Y, Mandelboim M, Regev-Yochay G.

Clin Microbiol Infect. 2024 Mar. 30(3):409-413. PMID: 38128780

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter Season.

Moss S, Jurkowicz M, Nemet I, Atari N, Kliker L, Abd-Elkader B, Gonen T, Martin ET, Lustig Y, Regev-Yochay G, Mandelboim M.

Vaccines (Basel). 2023 Oct 22. 11(10). PMID: 37897026

Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review.

Gilboa M, Baharav N, Melzer E, Regev-Yochay G, Yahav D.

Infect Dis Ther. 2023 Sep. 12(9):2223-2240. PMID: 37704801

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines.

Gonen T, Barda N, Asraf K, Joseph G, Weiss-Ottolenghi Y, Doolman R, Kreiss Y, Lustig Y, Regev-Yochay G.

JAMA Netw Open. 2023 09 05. 6(9):e2332813. PMID: 37682571

Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.

Muik A, Lui BG, Quandt J, Diao H, Fu Y, Bacher M, Gordon J, Toker A, Grosser J, Ozhelvaci O, Grikscheit K, Hoehl S, Kohmer N, Lustig Y, Regev-Yochay G, Ciesek S, Beguir K, Poran A, Vogler I, Türeci Ö, Sahin U.

Cell Rep. 2023 08 29. 42(8):112888. PMID: 37527039

Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study.

Joseph G, Cohen C, Rubin C, Murad H, Indenbaum V, Asraf K, Weiss-Ottolenghi Y, Segal-Lieberman G, Kreiss Y, Lustig Y, Regev-Yochay G.

Microorganisms. 2023 Jun 22. 11(7). PMID: 37512801